Mary Stuart

Senior Writer/Market Analyst

30 Years of Experience

About

Mary is a senior writer for MedTech Strategist and the editor of the “Start-Ups to Watch” department. She’s been reporting on medtech business strategies across all clinical areas for over 30 years. Mary is a key driver and expert in identifying important emerging technology and industry trends while backing up these insights with in-depth research including interviews with high-level executives and thought-leading clinicians. It’s the odd news item that makes one go “Huh,” she says, of her track record while reporting about treatments and technologies just as they’re emerging, and clearly articulating what’s different about those technologies. 

Mary has published articles in dynamic therapeutic areas including the paradigm shift in the treatment of heart failure; technological advances in neurology, especially closed-loop neurostimulation as well as new ways that make brain-sensing more widely available; how digital health can get removed healthcare from its silos to improve outcomes in chronic diseases; atrial fibrillation (exhaustively) and lung cancer, the final frontier in interventional medicine, among other diverse topics. A graduate of Smith College, Mary is ever the advocate of the benefits of a liberal arts education.

Articles from Mary Stuart:

Start-Ups

MedTech Catapult: A Springboard to MedTech Innovation in Singapore

Singapore possesses many of the capabilities needed to build successful medtech companies. MedTech Catapult, a national platform hosted by the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&D agency, aims to connect and build upon these strengths to accelerate promising innovations toward commercial success, and, in the process, to further strengthen Singapore’s medtech ecosystem.

Read Article